Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The objective of the B-Convinced study is to demonstrate the non-inferiority of beta-blocker
continuation compared to its interruption in patients with congestive heart failure who are
treated by a beta-blocker and present with an episode of heart failure worsening with
pulmonary oedema requiring hospital admission.
162 patients will be randomized in cardiology centers in France. Clinical status (primary
endpoint) will be evaluated with a standardized questionnaire 3 days after hospital
admission.